Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guizhen Yu

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Clinical Journal of the American Society of Nephrology : CJASN|September 13, 2019
Plasma Galactose-Deficient IgA1 and C3 and CKD Progression in IgA NephropathyPei Chen, Guizhen Yu, Xue Zhang, et al.
American Journal of Nephrology|September 24, 2024
Urinary Sodium Excretion and Kidney Disease Progression in IgA Nephropathy: A Cohort StudyGuizhen Yu, Xuliang Wang, Yijie Cheng, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 19, 2024
Urinary C4d and progression of kidney disease in IgA vasculitisGuizhen Yu, Jie Zhao, Meifang Wang, et al.
Accident; Analysis and Prevention|February 9, 2025
MineSim: A scenario-based simulation test system and benchmark for autonomous trucks in open-pit minesZhifa Chen, Guizhen Yu, Peng Chen, et al.
International Immunopharmacology|December 28, 2020
Immune characteristics of renal allograft donors with mesangial IgA depositionZi Wang, Xue Zhang, Wenke Han, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 12, 2019
Associations of ABO blood type and galactose-deficient immunoglobulin A1 with adverse outcomes in patients with IgA nephropathyManliu Wang, Jicheng Lv, Pei Chen, et al.
Renal Failure|December 3, 2025
Effect of finerenone on proteinuria reduction in IgA nephropathyGuizhen Yu, Meifang Wang, Xue Zhang, et al.
Renal Failure|March 30, 2026
ADAMTS13 ameliorates diabetic nephropathy by Nrf2/GPX4/eNOS signaling pathwayHonghong Wang, Jie Guo, Qingqing Wang, et al.
International Journal of Biological Sciences|March 9, 2026
ANXA1-mediated mTOR/FABP4 Inhibition Drives Antifibrotic Macrophage Reprogramming in Lupus NephritisJuan Tao, Qingyu Cheng, Pinjie Zhang, et al.
European Journal of Pharmacology|January 26, 2026
TGR5 rescues renal ischemia-reperfusion injury by suppressing ferroptosis and cAMP/PKA/Nrf2 axisSuhan Zhou, Honghong Wang, Huanhuan Zhu, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Clinical Journal of the American Society of Nephrology : CJASN|September 13, 2019
Plasma Galactose-Deficient IgA1 and C3 and CKD Progression in IgA NephropathyPei Chen, Guizhen Yu, Xue Zhang, et al.
American Journal of Nephrology|September 24, 2024
Urinary Sodium Excretion and Kidney Disease Progression in IgA Nephropathy: A Cohort StudyGuizhen Yu, Xuliang Wang, Yijie Cheng, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 19, 2024
Urinary C4d and progression of kidney disease in IgA vasculitisGuizhen Yu, Jie Zhao, Meifang Wang, et al.
Accident; Analysis and Prevention|February 9, 2025
MineSim: A scenario-based simulation test system and benchmark for autonomous trucks in open-pit minesZhifa Chen, Guizhen Yu, Peng Chen, et al.
International Immunopharmacology|December 28, 2020
Immune characteristics of renal allograft donors with mesangial IgA depositionZi Wang, Xue Zhang, Wenke Han, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 12, 2019
Associations of ABO blood type and galactose-deficient immunoglobulin A1 with adverse outcomes in patients with IgA nephropathyManliu Wang, Jicheng Lv, Pei Chen, et al.
Renal Failure|December 3, 2025
Effect of finerenone on proteinuria reduction in IgA nephropathyGuizhen Yu, Meifang Wang, Xue Zhang, et al.
Renal Failure|March 30, 2026
ADAMTS13 ameliorates diabetic nephropathy by Nrf2/GPX4/eNOS signaling pathwayHonghong Wang, Jie Guo, Qingqing Wang, et al.
International Journal of Biological Sciences|March 9, 2026
ANXA1-mediated mTOR/FABP4 Inhibition Drives Antifibrotic Macrophage Reprogramming in Lupus NephritisJuan Tao, Qingyu Cheng, Pinjie Zhang, et al.
European Journal of Pharmacology|January 26, 2026
TGR5 rescues renal ischemia-reperfusion injury by suppressing ferroptosis and cAMP/PKA/Nrf2 axisSuhan Zhou, Honghong Wang, Huanhuan Zhu, et al.
Pageof 4